OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Recommended Conferences for Medicine for Abortion

Medicine for Abortion


OMICS International Organizes 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

OMICS International Conferences will enhance the knowledge of all the participants in different fields and will be a varied combination of eminent speakers, industry professionals, social activist, students and research scholars. OMICS International pharma conferences are the novel developments and to consider, and conflate ideas and realities through practical experiences. The scope of these gatherings is extended by remarking key regulatory areas like Pharmaceutical Regulatory Affairs, Separation Techniques, Toxicology, Mass Spectrometry , Toxicogenomics and Drug Monitoring, Pain Medicine, Clinical Pharmacy, GMP and GLP quality control, followed by Bioavailability and Bioequivalence studies, Biosimilars and Pharmacognosy. Providing a chance, OMICS Group conferences host scientists, researchers, pharmaceutical organizations and all representatives of pharmaceutical company sectors can showcase their cogent findings and at the same time get exposed to a useful collection of research and latest developments.

The medicine for abortion is a pill that ends an early pregnancy. Generally, it is used up to 63 days after the first day of a woman's last period. The name for "the abortion pill" is mifepristone. Some of the medicines may cause serious birth defects if the pregnancy continues. The pill works by blocking the progesterone hormone. Without progesterone, lining of the uterus breaks down, and pregnancy cannot continue. In case of misoprostol it causes cramps and heavy bleeding. It usually lasts a few hours. More than half of women abort within four or five hours after taking the medicine. Other medicines which helps in termination of pregnancy are as follows: Cytotec oral, misoprostol oral, Pitocin injection, oxytocin injection, carboprost tromethamine intramuscular, Mifeprex oral, Prostin E2 vaginal, mifepristone oral, oxytocin in dextrose 5% intravenous, oxytocin in 0.9 % sodium chloride intravenous, Hemabate intramuscular, dinoprostone vaginal, oxytocin in dextrose 5%-LR intravenous, oxytocin in lactated ringers intravenous, oxytocin in dextrose 5%-0.9% sodium chloride intravenous and oxytocin in dextrose 5%-0.45% sodium chloride intravenous. These drugs are either taken orally or intravenously.
According to the WHO report since 2001, about ten women have died from clostridial toxic shock syndrome following early medical abortions using 200 mg mifepristone orally followed by 800 mcg misoprostol—nine vaginally without prophylactic antibiotics. In the year 2010, about 765,651 legally induced abortions were reported to CDC from 49 reporting different places. The abortion rate for 2010 was 14.6 abortions per 1,000 women aged 15–44 years and the abortion ratio was 228 abortions per 1,000 live births. In comparison to 2009 the total number and rate of reported abortions for 2010 decreased by 3%. Stable abortion ratio was observed changing only 0.4%. Additionally, from 2001 to 2010 the number, rate, and ratio of reported abortions decreased 9%, 10%, and 8%, respectively.
Women in their twenties accounted for the majority of abortions in 2010 and throughout the period of analysis. The majority of abortions in 2010 took place early in gestation: 91.9% of abortions were performed at ≤13 weeks’ gestation, and of the abortions performed at ≤13 weeks’ gestation, 71.7% were performed at ≤ 8 weeks’ gestation. In 2010, 17.7% of all abortions were medical abortions. One of the first oral abortion pills which were approved by the FDA in 2002, was Mifepristone. France and Sweden became two first European countries which approved abortion pills. In 2012, Mifepristone was included into Australia.

OMICS Group International is a combination of Open Access publications and worldwide international science conferences and events. It was established in the year 2007 with the aim of making the information on Sciences and technology ‘Open Access’.OMICS Group also organizes 300 International conferences annually across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions. OMICS International organizes Science Congress, World Summits, and International science conferences in India, USA, Dubai, Australia and Europe. OMICS Group Journals encourages original and well researched articles for publication. With the help of a strong 30, 000 experts as editorial board members and reviewers, OMICS Group journals uphold the standard review process. All the articles submitted for publication are subjected to a blind peer review. Upon incorporating the changes the articles are published online. Once approved for publication, these articles remain archived permanently in their respective repositories. OMICS Group Journals follow online tracking system where the authors can submit their articles online and track its status from time to time.
Upcoming conferences on medicine for abortion are
1.2014 Conference on Family Planning.
2.2015 North American Society for Pediatric and Adolescent Gynecology Annual Clinical and Research Meeting.
3.2016 North American Society for Pediatric and Adolescent Gynecology Annual 4.Clinical and Research Meeting.
5.Combined Abdominal and OB Ultrasoun.
d 6.10th Asia Pacific Congress in Maternal Fetal Medicine.
7.Women's Health - Eastern Mediterranean Cruise Conference .
8.International Fetal Medicine and Surgery Society 33rd Annual Conference.
11.The 11th FIAPAC Conference: "Task sharing in Abortion Care.
Upcoming workshop and symposium are:
Introducing our Online Abortion and Reproductive Technology Symposium.
Congress Book Workshop: Canadian Abortion Politics: Twenty-Five Years After Morgentaler.
North American Forum on Family Planning and NAF's Residency Training Workshop.
Various companies producing medicines for abortion are:
1.Mifeprex-USA .
2.Hoechst AG-Europe.
3.Associations on medicine for abortion are: .
4.American Medical Association.
5.American Pregnancy Association.
6.World Medical Association.
7.Induced Abortion - Canadian Medical Association .
8.National Abortion Federation. .
OMICS group conferences relevant to medicine for abortion are as follows:
1.International Conference on Women’s Health.
2.Gynecology & Obstetrics .
3.The 2nd International Conference on Gynecology & Obstetrics. .

This page will be updated regularly.

This page was last updated on 17th Apr, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising